QIS, Inc. was actively engaged in performing cGLP audits for our organization. In the midst of executing that task, QIS, Inc. eagerly switched gears and was instrumental in helping us reach our goal to submit the grant proposal on time. And the grant proposal proved successful for us
Blood, Biologics and Tissue Products
Some of the most challenging areas to maintain compliance to FDA regulations include blood, blood derived products, and blood screening tests, tissue and bone based products, and biologics. QIS provides…
Read More